Andara
Therapeutics
Therapeutics
Transformative immune tolerizing therapies for autoimmune diseases
Andara Therapeutics is developing a precision immune tolerance platform designed to induce durable remission in autoimmune disease, without lifelong immunosuppression. Our full website is on its way. Until then, we are glad to hear from partners, investors and researchers.
Stage
Clinical
Phase 1b under way in adults with stage 3 type 1 diabetes.
Indications
Type 1 diabetes · Rheumatoid arthritis
One platform, applied across autoimmune disease.
Where we work
Belgium · Australia
Clinical activities conducted with The University of Queensland.